{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:26:54Z","timestamp":1793608014096,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129159","type":"journal-article","created":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:24:39Z","timestamp":1789259079000},"page":"129159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluation of the efficacy and duration of immunity of a bivalent subunit vaccine containing porcine circovirus type 2a and type 2d antigen"],"prefix":"10.1016","volume":"92","author":[{"given":"Troy J.","family":"Kaiser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Jarrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hinds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Dorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando L.","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Eichmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129159_bb0005","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00705-024-06107-2","article-title":"2024 taxonomy update for the family Circoviridae","volume":"169","author":"Varsani","year":"2024","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2026.129159_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208585","article-title":"Porcine circovirus 2 (PCV-2) genotype update and proposal of a new genotyping methodology","volume":"13","author":"Franzo","year":"2018","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129159_bb0015","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3390\/pathogens9121049","article-title":"Porcine circovirus 2 genotypes, immunity and vaccines: multiple genotypes but one single serotype","volume":"9","author":"Franzo","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.vaccine.2026.129159_bb0020","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/vetr.70074","article-title":"Towards a unified nomenclature for diseases associated with porcine circovirus infections","volume":"197","author":"Segal\u00e9s","year":"2025","journal-title":"Vet Rec"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129159_bb0025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/vetsci9030110","article-title":"Revisiting porcine circovirus disease diagnostic criteria in the current epidemiological context","volume":"9","author":"Segal\u00e9s","year":"2022","journal-title":"Vet Sci"},{"key":"10.1016\/j.vaccine.2026.129159_bb0030","doi-asserted-by":"crossref","first-page":"1500498","DOI":"10.3389\/fmicb.2024.1500498","article-title":"Updated phylogeography and population dynamics of PCV2 genotypes","volume":"15","author":"Franzo","year":"2024","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129159_bb0035","first-page":"3183","article-title":"Epidemiological analysis of PCV2 circulation in Viet Nam","volume":"26","author":"Nguyen","year":"2023","journal-title":"Sci Tech Dev J"},{"key":"10.1016\/j.vaccine.2026.129159_bb0040","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1007\/s11259-024-10521-x","article-title":"Molecular evolution and genotype shift of PCV2 in Vietnam","volume":"48","author":"Lai","year":"2024","journal-title":"Vet Res Commun"},{"key":"10.1016\/j.vaccine.2026.129159_bb0045","series-title":"Enhancing PCV2 control: Homologous vs heterologous vaccination","author":"Kroeger","year":"2025"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129159_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10080979","article-title":"A comparison of pathogenicity and virulence of three porcine circovirus type 2 (PCV2) genotypes (a, b, and d) in pigs singularly inoculated with PCV2 and dually inoculated with mycoplasma hyopneumoniae and PCV2","volume":"10","author":"Oh","year":"2021","journal-title":"Pathogens"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129159_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10070891","article-title":"A comparison of virulence of three porcine circovirus type 2 (PCV2) genotypes (a, b, and d) in pigs singularly inoculated with PCV2 and dually inoculated with PCV2 and porcine reproductive and respiratory syndrome virus","volume":"10","author":"Suh","year":"2021","journal-title":"Pathogens"},{"issue":"18","key":"10.1016\/j.vaccine.2026.129159_bb0060","article-title":"Speculative review on the feasibility of porcine circovirus 2 elimination","volume":"15","author":"Segal\u00e9s","year":"2025","journal-title":"Animals (Basel)"},{"key":"10.1016\/j.vaccine.2026.129159_bb0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.vetmic.2014.05.003","article-title":"Can PCV2 infection be eradicated by mass vaccination?","volume":"172","author":"Feng","year":"2014","journal-title":"Vet Microbiol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2026.129159_bb0070","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.vetmic.2015.02.001","article-title":"Carbopol improves immune responses","volume":"176","author":"Mair","year":"2015","journal-title":"Vet Microbiol"},{"issue":"19","key":"10.1016\/j.vaccine.2026.129159_bb0075","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.vaccine.2016.03.025","article-title":"Carbopol immune response","volume":"34","author":"Gartlan","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129159_bb0080","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/v17040554","article-title":"PCV2d + Mhyo vaccine efficacy","volume":"17","author":"P\u00e1lmai","year":"2025","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129159_bb0085","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3390\/vaccines13070681","article-title":"Tri-valent PCV2 vaccine efficacy","volume":"13","author":"Allen","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.129159_bb0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.trivac.2015.04.002","article-title":"Combined PCV2 + Mhyo vaccine","volume":"4","author":"Witvliet","year":"2015","journal-title":"Trials Vaccinol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129159_bb0095","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s13337-025-00947-5","article-title":"Diversity of PCV2 genotypes","volume":"36","author":"Malwade","year":"2025","journal-title":"Virusdisease"},{"key":"10.1016\/j.vaccine.2026.129159_bb0100","article-title":"PCV2d prevalence over other genotypes","volume":"15","author":"Faustini","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2026.129159_bb0105","article-title":"Prevalence and phylogenetic analysis of PCV2 and PCV3","volume":"9","author":"Yang","year":"2022","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.vaccine.2026.129159_bb0110","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.rvsc.2015.10.006","article-title":"Genetic diversity of PCV2","volume":"103","author":"Ssemadaali","year":"2015","journal-title":"Res Vet Sci"},{"issue":"9","key":"10.1016\/j.vaccine.2026.129159_bb0115","article-title":"Field efficacy trial of recombinant PCV2d vaccine","volume":"11","author":"Ju","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2026.129159_bb0120","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.vetmic.2014.09.016","article-title":"Effect of PCV2 load on ADG","volume":"174","author":"L\u00f3pez-Soria","year":"2014","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2026.129159_bb0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40813-019-0128-7","article-title":"Effect of maternally derived antibodies on performance and PCV2 viremia","volume":"5","author":"Figueras-Gourgues","year":"2019","journal-title":"Porcine Health Manag"},{"key":"10.1016\/j.vaccine.2026.129159_bb0130","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1038\/s41598-024-53624-w","article-title":"Efficacy evaluation of a bivalent subunit vaccine against classical swine fever virus and porcine circovirus type 2","volume":"14","author":"Chen","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2026.129159_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2026.1849112","article-title":"Preparation and immunological effects of a bivalent subunit candidate vaccine based on the PCV-Cap-2-3 gene engineered from baculovirus","volume":"13","author":"Liu","year":"2026","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.vaccine.2026.129159_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127303","article-title":"Assessment of homologous and heterologous PCV2 vaccine efficacy in a PCV2d\/PRRSV co-challenge model","volume":"60","author":"Kroeger","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129159_bb0145","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13567-015-0157-4","article-title":"PCV2 vaccination induces IFN-\u03b3\/TNF-\u03b1 co-producing T cells with a potential role in protection","volume":"46","author":"Koinig","year":"2015","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2026.129159_bb0150","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41541-025-01138-5","article-title":"Cellular immune signatures and differences of four porcine circovirus type 2 vaccines to heterologous PCV2d infection","volume":"10","author":"Li","year":"2025","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2026.129159_bb0155","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/1746-6148-8-194","article-title":"Reduction of porcine circovirus type 2 (PCV2) viremia by a reformulated inactivated chimeric PCV1-2 vaccine-induced humoral and cellular immunity after experimental PCV2 challenge","volume":"8","author":"Seo","year":"2012","journal-title":"BMC Vet Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:36:19Z","timestamp":1793604979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26009680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":31,"alternative-id":["S0264410X26009680"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129159","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the efficacy and duration of immunity of a bivalent subunit vaccine containing porcine circovirus type 2a and type 2d antigen","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129159"}}